Accounting for symptomatic and asymptomatic in a SEIR-type model of COVID-19
From MaRDI portal
Publication:5001296
DOI10.1051/mmnp/2020021zbMath1467.92169arXiv2004.01805OpenAlexW3035815753MaRDI QIDQ5001296
Randy L. Caga-anan, Cheryl Q. Mentuda, Youcef Mammeri, Jayrold P. Arcede
Publication date: 19 July 2021
Published in: Mathematical Modelling of Natural Phenomena (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2004.01805
Related Items (7)
Social distancing versus early detection and contacts tracing in epidemic management ⋮ Quantifying the Effects of Non-Pharmaceutical and Pharmaceutical Interventions Against Covid-19 Epidemic in the Republic of Korea: Mathematical Model-Based Approach Considering Age Groups and the Delta Variant ⋮ Optimal control and bifurcation analysis of SEIHR model for COVID-19 with vaccination strategies and mask efficiency ⋮ A reaction-diffusion system to better comprehend the unlockdown: application of SEIR-type model with diffusion to the spatial spread of COVID-19 in France ⋮ Optimal control for a COVID-19 model accounting for symptomatic and asymptomatic ⋮ Short-term predictions and prevention strategies for COVID-19: a model-based study ⋮ Effect of vaccination to COVID-19 disease progression and herd immunity
Uses Software
Cites Work
This page was built for publication: Accounting for symptomatic and asymptomatic in a SEIR-type model of COVID-19